10:55:02 EDT Sat 04 May 2024
Enter Symbol
or Name
USA
CA



T:MDP - MEDEXUS PHARMACEUTICALS INC. J - https://www.medexus.ca/
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
MDP - T  0.51.78·1.821.11.79+0.021.187.31491231.81  1.84  1.733.53  1.1215:59:59May 0115 min RT 2¢
TSX - T0.51.78·1.821.11.79+0.021.144.275601.81  1.84  1.733.53  1.1215:57:2915 min
NEO ATS - U 1.80+0.031.78.415141.83  1.83  1.7515:57:2915 min
Alpha - A 1.80+0.031.715.42761.80  1.80  1.7615:54:0915 min
Pure - P 1.78+0.010.67.112141.82  1.82  1.7815:43:0115 min
Chi-X - X 1.770.7131.78  1.78  1.7615:54:0915 min
CX2 - H 1.79+0.021.110.117161.81  1.83  1.7515:59:5915 min
CXD - D 1.80+0.031.70.3021.80  1.80  1.8010:55:0215 min
TriAct - M 1.771.228    Sep 11-2015 min

Recent Trades - Last 10 of 123
Time ETExPriceChangeVolumeBuyerSellerMarkers
15:59:59H1.790.0220079 CIBC1 AnonymousK
15:57:29M1.800.03751 Anonymous2 RBC
15:57:29H1.800.035002 RBC2 RBCK
15:57:29H1.800.036002 RBC1 AnonymousK
15:57:29M1.790.022001 Anonymous79 CIBC
15:57:29M1.790.024001 Anonymous1 Anonymous
15:57:29T1.790.021001 Anonymous79 CIBCK
15:57:29U1.800.031,0002 RBC1 AnonymousK
15:54:09A1.800.031,7007 TD Sec39 Merrill LynchK
15:54:09X1.77 3007 TD Sec39 Merrill LynchK

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins
Date ETSymbolPriceTypeHeadline
2024-05-01 17:47C:MDP1.75News ReleaseMedexus's Metoject patent no longer in effect in Canada
2024-03-26 12:03C:MDP1.70News ReleaseMedexus gets Ixinity supplemental biologics licence OK
2024-02-07 19:36C:MDP2.70SEDAR Interim Financial StatementsSEDAR Interim Financial Statements
2024-02-07 19:36C:MDP2.70SEDAR Interim MD & ASEDAR Interim MD & A
2024-02-07 18:09C:MDP2.70News ReleaseMedexus loses $500,000 (U.S.) in fiscal Q3 2024
2024-01-30 10:37C:MDP2.49News ReleaseMedexus to release Q3 2024 results Feb. 7
2024-01-08 10:44C:MDP2.87News ReleaseMedexus nail lacquer accepted for Health Canada review
2023-11-08 18:40C:MDP2.05News ReleaseMedexus loses $1.09-million (U.S.) in Q2 fiscal 2024
2023-11-08 07:56C:MDP2.05SEDAR Interim Financial StatementsSEDAR Interim Financial Statements
2023-11-08 07:44C:MDP2.05SEDAR Interim MD & ASEDAR Interim MD & A
2023-11-01 12:27C:MDP2.03News ReleaseMedexus to release Q2 2024 results Nov. 8
2023-10-17 13:47C:MDP2.45News ReleaseMedexus completes $1.5M overallotment option
2023-10-16 13:11C:MDP2.49News ReleaseMedexus Pharmaceuticals repays convertible debentures
2023-10-06 21:01C:MDP2.79MiscellaneousMedexus 6% debentures to be delisted Oct. 16
2023-10-06 11:06C:MDP2.74News ReleaseMedexus Pharmaceuticals closes $10M public offering
2023-10-04 19:30C:MDP3.00Prospectus ApprovedMedexus Pharmaceuticals prospectus offering
2023-09-28 19:45C:MDP2.96News ReleaseMedexus amends outside date under medac licensing deal
2023-09-21 17:12C:MDP3.00News ReleaseMedexus shareholders elect seven directors at AGM
2023-09-05 19:05C:MDP3.13News ReleaseMedexus Pharmaceuticals arranges $10M public offering
2023-09-05 14:56C:MDPSEDAR Final Short Form ProspectusSEDAR Final Short Form Prospectus